English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Breast carcinoma is one of the leading causes of cancer related mortality in females. It is the most common cancer among women in India with an incidence of approximately 1,45,000 cases annually and around 70,000 deaths annually [1]. In developing countries peak incidence of breast carcinoma occurs in 45 to 60 years. Despite various screening modalities, diagnosis and treatment employed, many women die from disease each year. A number of established prognostic indicators exist of breast cancer, which includes tumor size, lymph node status, histological grade, tumor type, vascular invasion and hormone receptor Abstract

Prognostic Significance of Microvessel Density as Assessed by anti CD34 Monoclonal Antibody in Invasive Ductal Carcinoma of Breast